Oramed Pharm share price logo

Oramed Pharm

NASDAQ: ORMP

$4.13

-0.10

(-2.25%)

Live

as on

Oramed Pharm Stock Performance

as on October 31, 2026 at 3:26 am IST

  • Day's High

    $4.13
    $4.29

    3.87%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.09
    $5.47
    downward going graph

    49.39%

    Downside

    32.45%

    Upside

    downward going graph

Oramed Pharm share price movements today

Previous Close
$4.23
Open
$4.24
Volume
73.3K
Market Cap
$173.0M
Dividend Yield
6.58%
Day's Low - High
$4.13 - $4.29
52 Week Low - High
$2.09 - $5.47

Oramed Pharm Historical Returns

1 Month Return
-9.42 %
3 Month Return
+ 2.67 %
1 Year Return
+ 76.25 %
3 Year Return
+ 125 %
5 Year Return
-81.93 %

Oramed Pharm Stock Fundamentals & Key Indicators

Check Oramed Pharm market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$173.0M

EPS (TTM)

4.23

Dividend Yield

6.58%

Quarterly Earnings Growth YOY

4.93%

PE Ratio (TTM)

0.98

Industry PE ratio

-3.27

PEG Ratio

0.00

EBITDA

151.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

72.96%

Oramed Pharm vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oramed Pharm with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Hold$173.0M-81.93%0.980.00%6.58%
Neutral$85.5B-35.47%-26.84-12.57%0.00%
StrongBuy$134.2B192.00%30.5886.04%0.00%
Buy$83.7B27.94%19.4284.86%0.45%

Stock Returns calculator for Oramed Pharm Stock including INR - Dollar returns

The Oramed Pharm stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Oramed Pharm investment value today

Current value as on today

₹1,84,350

Returns

₹84,350

(+84.35%)

Returns from Oramed Pharm Stock

₹72,083 (+72.08%)

Dollar Impact

₹12,267 (+12.27%)

Analyst Recommendation on Oramed Pharm Stock

Based on 7 analysts

HOLD

0.00%

Buy

57.14%

Hold

42.86%

Sell

Based on 7 analysts, 57.14% of analysts recommend a 'HOLD' rating for Oramed Pharm. Average target price of $7

Oramed Pharm Share Price Target

Get share price movements and forecasts by analysts on Oramed Pharm.

What analysts predicted

41%UPSIDE

Target Price

$7

Current Price

$4.13

Analyzed by

7 Analysts

Target

$7.00

Oramed Pharm target price $7, a slight upside of 41% compared to current price of $4.13. According to 7 analysts rating.

Indian Investors' Interest in Oramed Pharm Stock

Search interest for Oramed Pharm Stock has increased by 13% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:13% versus previous 30 day period

Oramed Pharm Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Jun 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Jun 2026
Total Revenue
-
-
-
-
-
2
-
-
-
-
Gross Profit
-
0
-
-
0
0
-
0
0
-
Operating Income
-2
-3
-2
-3
-3
-4
-2
-2
-3
-2
EBITDA
-2
-3
2
-18
-3
-4
13
59
-3
101
Interest Expense
0
1
0
-
-
2
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
13
1
-18
-9
-7
13
59
49
101
Income Tax Expense
-
-
-
1
0
0
0
11
11
23
Net Income
-3
13
1
-19
-10
-7
13
48
38
78
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.65%
0.00%
0.00%
0.00%
0.00%

Oramed Pharm Annual Profit & Loss

All numbers in Millions USD

Aug 2017
Aug 2018
Aug 2019
Aug 2020
Aug 2021
Dec 2022
Sep 2023
Dec 2024
Dec 2025
Total Revenue
2
2
2
2
2
2
1
-
2
Gross Profit
2
2
2
2
2
2
1
-
0
Operating Income
-10
-13
-14
-11
-24
-40
-15
-12
-15
EBITDA
-10
-13
-14
-11
-24
-40
7
-14
75
Interest Expense
0
0
-
-
-
-
3
0
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-12
-14
-11
-22
-37
5
-15
75
Income Tax Expense
0
0
0
-
-
0
-
3
11
Net Income
-10
-12
-14
-11
-22
-37
5
-19
64
Net Profit Margin
92.39%
96.49%
96.67%
96.68%
100.00%
100.00%
100.00%
0.00%
0.65%

Oramed Pharm Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Jun 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Jun 2026
Net Income
-3
13
1
-19
-10
-7
13
48
38
78
Operating Cash Flow
0
-1
-1
-7
-1
-3
-3
-1
-2
0
Investing Cash Flow
-72
29
29
-33
15
23
-55
38
-19
4
Financing Cash Flow
72
-24
-19
-1
-1
-
0
0
-10
-1
Change in Cash
-1
3
9
-42
12
20
-58
36
-32
2

Oramed Pharm Annual Cash Flow

All numbers in Millions USD

Aug 2017
Aug 2018
Aug 2019
Aug 2020
Aug 2021
Dec 2022
Sep 2023
Dec 2024
Dec 2025
Net Income
-10
-12
-14
-11
-22
-36
5
-19
64
Operating Cash Flow
-5
-14
-12
-12
-21
-28
-10
-8
-9
Investing Cash Flow
4
-7
11
4
-22
30
-73
105
5
Financing Cash Flow
1
22
-
23
101
11
51
-52
-4
Change in Cash
0
1
-1
15
57
-36
-31
45
-8

Global Institutional Holdings in Oramed Pharm

Check out the Institutions with significant holdings in Oramed Pharm.

Funds
Holdings
iShares
2.99%
Fidelity Salem Street Trust
1.03%
Vanguard
0.58%
DFA
0.30%
SCHWAB CAPITAL TRUST
0.20%

Insights on Oramed Pharm

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, ORMP stock has moved up by 76.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 691.6% return, outperforming this stock by 615.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 200.7% return, outperforming this stock by 75.7%

About Oramed Pharm

Oramed Pharmaceuticals Inc., founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutical treatments. Their primary focus is on creating orally ingested capsules or pills for the delivery of polypeptides, particularly aimed at managing diabetes. The company's leading product, ORMD-0801, is an oral insulin capsule that has successfully completed Phase II clinical trials for patients with diabetes. Oramed is also advancing ORMD-0901, an oral glucagon-like peptide-1 (GLP-1) capsule, which has concluded Phase I clinical trials for the treatment of type 2 diabetes. Additionally, an oral leptin capsule for weight loss is currently under development. The firm was originally incorporated as Integrated Security Technologies, Inc., before officially changing its name to Oramed Pharmaceuticals Inc. in April 2006.
OrganisationOramed Pharm
Headquarters1185 Avenue of the Americas, New York City, NY, 10036, US
IndustryBiotechnology
CEONadav Kidron

Key Management of Oramed Pharm

Name

Title

Mr. Nadav Kidron Esq.

President, CEO & Executive Chairman

Mr. Joshua Hexter

Chief Operating & Business Officer

Dr. Miriam Kidron Ph.D.

Chief Scientific Officer & Director

Mr. Avraham Gabay

CFO, Treasurer & Secretary

FAQs

What is Oramed Pharm share price today?

Oramed Pharm share price today is $4.13 as on . Oramed Pharm share today touched a day high of $4.29 and a low of $4.13.

What is the 52 week high and 52 week low for Oramed Pharm share?

Oramed Pharm share touched a 52 week high of $5.47 on and a 52 week low of $2.09 on . Oramed Pharm stock price today i.e. is trending at $4.13,which is 24.50% down from its 52 week high and 97.61% up from its 52 week low.

What is Oramed Pharm's market capitalisation today?

Oramed Pharm market capitalisation is $0.00T as on .

How to invest in Oramed Pharm Stock (ORMP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Oramed Pharm on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Oramed Pharm Stock (ORMP) from India?

Indian investors can start investing in Oramed Pharm (ORMP) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Oramed Pharm stock (as per the Rupee-Dollar exchange rate as on ). Based on Oramed Pharm share’s latest price of $4.13 as on October 30, 2026 at 9:56 pm IST, you will get 2.4213 shares of Oramed Pharm. Learn more about fractional shares .

What are the returns that Oramed Pharm has given to Indian investors in the last 5 years?

Oramed Pharm stock has given -81.93% share price returns and 27.1% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?